Skip to main content
Top
Published in: Translational Stroke Research 4/2014

01-08-2014 | Original Article

δ-Opioid Receptors and Inflammatory Cytokines in Hypoxia: Differential Regulation Between Glial and Neuron-Like Cells

Authors: Qinyu Wang, Dongman Chao, Tao Chen, Harleen Sandhu, Ying Xia

Published in: Translational Stroke Research | Issue 4/2014

Login to get access

Abstract

Emerging evidence suggests that the δ-opioid receptor (DOR) is neuroprotective against hypoxic stress. Since inflammatory factors play an important role in hypoxic injury, we sought to determine if DOR modulates cellular inflammatory process in hypoxia. Since astrocytes produce inflammatory cytokines and play a major role in inflammatory response to hypoxia, we exposed cultured rat astrocytes to severe hypoxia (0.1 % O2) for 3–6 h to examine if DOR activation altered hypoxia-induced expression of proinflammatory cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) along with cell viability. To examine a differential DOR-mediated modulation between glial and neuron-like cells, we also conducted the same experiments in differentiated PC-12 cells. We found that hypoxia reduced cell viability in both astrocytes and PC-12 cells, and DOR activation with UFP-512 (5 μM) effectively protected both the cells against hypoxic insult. Hypoxia markedly increased TNF-α levels in the astrocytes (p < 0.05); however, the same hypoxic stress reduced TNF-α levels in the PC-12 cells. Exogenous addition of TNF-α to the culture media further worsened the hypoxia-induced damage in PC-12 cells. Hypoxia increased the DOR-expression in astrocytes but not in PC-12 cells. DOR-activation reversed the hypoxia-induced changes in TNF-α levels in both the cells. In contrast, the IL-1β levels did not significantly alter in astrocytes and PC-12 cells when exposed to the same hypoxic conditions or following DOR activation. Our novel data suggest that DOR activation inhibits TNF-α mediated inflammatory processes following exposure to severe hypoxia with a differential regulation between glial vs. neuron-like cells.
Literature
1.
go back to reference Lenihan CR, Taylor CT. The impact of hypoxia on cell death pathways. Biochem Soc Trans. 2013;41:657–63.PubMedCrossRef Lenihan CR, Taylor CT. The impact of hypoxia on cell death pathways. Biochem Soc Trans. 2013;41:657–63.PubMedCrossRef
2.
go back to reference Beitner-Johnson D, Leibold J, Millhorn DE. Hypoxia regulates the cAMP- and Ca2+/calmodulin signaling systems in PC12 sells. Biochem Biophys Res Commun. 1998;242:61–6.PubMedCrossRef Beitner-Johnson D, Leibold J, Millhorn DE. Hypoxia regulates the cAMP- and Ca2+/calmodulin signaling systems in PC12 sells. Biochem Biophys Res Commun. 1998;242:61–6.PubMedCrossRef
3.
go back to reference Soroko SI, Burykh ÉA, Bekshaev SS, Rozhkov VP. Individual systemic reactions of human organism under acute hypoxia. Boĭko ERRoss Fiziol Zh Im I M Sechenova. 2012;98:1396–415. Soroko SI, Burykh ÉA, Bekshaev SS, Rozhkov VP. Individual systemic reactions of human organism under acute hypoxia. Boĭko ERRoss Fiziol Zh Im I M Sechenova. 2012;98:1396–415.
4.
go back to reference Frankola KA, Greig NH, Luo W, Tweedie D. Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol Disord Drug Targets. 2011;10:391–403.PubMedCrossRef Frankola KA, Greig NH, Luo W, Tweedie D. Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol Disord Drug Targets. 2011;10:391–403.PubMedCrossRef
5.
go back to reference Cumiskey D, Curran BP, Herron CE, O’Connor JJ. A role for inflammatory mediators in the IL-18 mediated attenuation of LTP in the rat dentate gyrus. Neuropharmacology. 2007;52:1616–23.PubMedCrossRef Cumiskey D, Curran BP, Herron CE, O’Connor JJ. A role for inflammatory mediators in the IL-18 mediated attenuation of LTP in the rat dentate gyrus. Neuropharmacology. 2007;52:1616–23.PubMedCrossRef
6.
go back to reference Mishra A, Kim HJ, Shin AH, Thayer SA. Synapse loss induced byinterleukin-1beta requires pre- and post-synaptic mechanisms. J Neuroimmune Pharmacol. 2012;7:571–8.PubMedCentralPubMedCrossRef Mishra A, Kim HJ, Shin AH, Thayer SA. Synapse loss induced byinterleukin-1beta requires pre- and post-synaptic mechanisms. J Neuroimmune Pharmacol. 2012;7:571–8.PubMedCentralPubMedCrossRef
7.
go back to reference Cieślak M, Wojtczak A, Cieślak M. Relationship between the induction of inflammatory processes and infectious diseases in patients with ischemic stroke. Acta Biochim Pol. 2013;60:345–9.PubMed Cieślak M, Wojtczak A, Cieślak M. Relationship between the induction of inflammatory processes and infectious diseases in patients with ischemic stroke. Acta Biochim Pol. 2013;60:345–9.PubMed
9.
go back to reference Page SJ. Selective TNF, inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs. 2013;27:395–7.PubMedCentralPubMedCrossRef Page SJ. Selective TNF, inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs. 2013;27:395–7.PubMedCentralPubMedCrossRef
10.
go back to reference Otter SJ, Lucas K, Springett K, Moore A, Davies K, Young A, et al. Comparison of foot pain and foot care among rheumatoid arthritis patients taking and not taking anti-TNFα therapy: an epidemiological study. Rheumatol Int. 2011;31:1515–9.PubMedCrossRef Otter SJ, Lucas K, Springett K, Moore A, Davies K, Young A, et al. Comparison of foot pain and foot care among rheumatoid arthritis patients taking and not taking anti-TNFα therapy: an epidemiological study. Rheumatol Int. 2011;31:1515–9.PubMedCrossRef
11.
go back to reference Wilson LH, Eliason MJ, Leiferman KM, Hull CM, Powell DL. Treatment of refractory chronic urticaria with tumor necrosis factor-alpha inhibitors. J Am Acad Dermatol. 2011;64:1221–2.PubMedCrossRef Wilson LH, Eliason MJ, Leiferman KM, Hull CM, Powell DL. Treatment of refractory chronic urticaria with tumor necrosis factor-alpha inhibitors. J Am Acad Dermatol. 2011;64:1221–2.PubMedCrossRef
12.
go back to reference Tweedie D, Sambamurti K, Greig NH. TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets. Curr Alzheimer Res. 2007;4:378–85.PubMedCrossRef Tweedie D, Sambamurti K, Greig NH. TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets. Curr Alzheimer Res. 2007;4:378–85.PubMedCrossRef
13.
go back to reference He X, Sandhu HK, Yang Y, Hua F, Belser N, Kim DH, et al. Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events. Cell Mol Life Sci. 2013;70:2291–303. He X, Sandhu HK, Yang Y, Hua F, Belser N, Kim DH, et al. Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events. Cell Mol Life Sci. 2013;70:2291–303.
14.
go back to reference Zhang JH, Gibney GT, Xia Y. Neuroprotective role of delta-opioid receptors in cortical neurons. Am J Physiol Cell Physiol. 2002;282:C1225–34.PubMedCrossRef Zhang JH, Gibney GT, Xia Y. Neuroprotective role of delta-opioid receptors in cortical neurons. Am J Physiol Cell Physiol. 2002;282:C1225–34.PubMedCrossRef
15.
go back to reference Zhang J, Qian H, Zhao P, Hong SS, Xia Y. Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-opioid receptor. Stroke. 2006;37:1094–9.PubMedCrossRef Zhang J, Qian H, Zhao P, Hong SS, Xia Y. Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-opioid receptor. Stroke. 2006;37:1094–9.PubMedCrossRef
16.
go back to reference Ma MC, Qian H, Ghassemi F, Zhao P, Xia Y. Oxygen sensitive delta-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J Biol Chem. 2005;280:16208–18.PubMedCrossRef Ma MC, Qian H, Ghassemi F, Zhao P, Xia Y. Oxygen sensitive delta-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J Biol Chem. 2005;280:16208–18.PubMedCrossRef
18.
go back to reference Husain S, Abdul Y, Potter DE. Non-analgesic effects of opioids: neuroprotection in the retina. Curr Pharm Des. 2012;18:6101–8.PubMedCrossRef Husain S, Abdul Y, Potter DE. Non-analgesic effects of opioids: neuroprotection in the retina. Curr Pharm Des. 2012;18:6101–8.PubMedCrossRef
19.
go back to reference Tang CW, Feng WM, Du HM, Bao Y, Zhu M. Delayed administration of D-Ala2-D-Leu5-enkephalin, a delta-opioid receptor agonist, improves survival in a rat model of sepsis. Tohoku J Exp Med. 2011;224:69–76.PubMedCrossRef Tang CW, Feng WM, Du HM, Bao Y, Zhu M. Delayed administration of D-Ala2-D-Leu5-enkephalin, a delta-opioid receptor agonist, improves survival in a rat model of sepsis. Tohoku J Exp Med. 2011;224:69–76.PubMedCrossRef
20.
go back to reference Cerbai F, Lana D, Nosi D, Petkova-Kirova P, Zecchi S, Brothers HM, et al. The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus. PLoS One. 2012;7:e45250.PubMedCentralPubMedCrossRef Cerbai F, Lana D, Nosi D, Petkova-Kirova P, Zecchi S, Brothers HM, et al. The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus. PLoS One. 2012;7:e45250.PubMedCentralPubMedCrossRef
21.
go back to reference Benjamins JA. Direct effects of secretory products of immune cells on neurons and glia. J Neurol Sci. 2013;333:30–6.PubMedCrossRef Benjamins JA. Direct effects of secretory products of immune cells on neurons and glia. J Neurol Sci. 2013;333:30–6.PubMedCrossRef
22.
23.
go back to reference Balboni G, Salvadori S, Guerrini R, Negri L, Giannini E, Jinsmaa Y, et al. Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore. J Med Chem. 2002;45:5556–63.PubMedCrossRef Balboni G, Salvadori S, Guerrini R, Negri L, Giannini E, Jinsmaa Y, et al. Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore. J Med Chem. 2002;45:5556–63.PubMedCrossRef
24.
go back to reference Chao D, Bazzy-Asaad A, Balboni G, Xia Y. Delta-, but not mu-, opioid receptor stabilizes K(+) homeostasis by reducing Ca(2+) influx in the cortex during acute hypoxia. J Cell Physiol. 2007;212:60–7.PubMedCrossRef Chao D, Bazzy-Asaad A, Balboni G, Xia Y. Delta-, but not mu-, opioid receptor stabilizes K(+) homeostasis by reducing Ca(2+) influx in the cortex during acute hypoxia. J Cell Physiol. 2007;212:60–7.PubMedCrossRef
26.
go back to reference Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10(1):45–65.PubMedCrossRef Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10(1):45–65.PubMedCrossRef
27.
go back to reference Taoufik E, Tseveleki V, Chu SY, Tselios T, Karin M, Lassmann H, et al. Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB. Brain. 2011;134:2722–35.PubMedCrossRef Taoufik E, Tseveleki V, Chu SY, Tselios T, Karin M, Lassmann H, et al. Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB. Brain. 2011;134:2722–35.PubMedCrossRef
28.
go back to reference Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, Begni B, et al. Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab. 1999;19:1004–9.PubMedCrossRef Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, Begni B, et al. Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab. 1999;19:1004–9.PubMedCrossRef
29.
go back to reference Smith C, Emsley H, Gavin C, Georgiou R, Vail A, Barberan E, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004;4:2.PubMedCentralPubMedCrossRef Smith C, Emsley H, Gavin C, Georgiou R, Vail A, Barberan E, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004;4:2.PubMedCentralPubMedCrossRef
31.
go back to reference Shrivastava K, Llovera G, Recasens M, Chertoff M, Giménez-Llort L, Gonzalez B, et al. Temporal expression of cytokines and signal transducer and activator of transcription factor 3 activation after neonatal hypoxia/ischemia in mice. Dev Neurosci. 2013;35:212–25.PubMedCrossRef Shrivastava K, Llovera G, Recasens M, Chertoff M, Giménez-Llort L, Gonzalez B, et al. Temporal expression of cytokines and signal transducer and activator of transcription factor 3 activation after neonatal hypoxia/ischemia in mice. Dev Neurosci. 2013;35:212–25.PubMedCrossRef
32.
go back to reference Ezquer ME, Valdez SR, Seltzer AM. Inflammatory responses of the substantia nigra after acute hypoxia in neonatal rats. Exp Neurol. 2006;197(2):391–8.PubMedCrossRef Ezquer ME, Valdez SR, Seltzer AM. Inflammatory responses of the substantia nigra after acute hypoxia in neonatal rats. Exp Neurol. 2006;197(2):391–8.PubMedCrossRef
33.
go back to reference Tuttolomondo A, Di Raimondo D, di Sciacca R, Pinto A, Licata G. Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des. 2008;14:3574–89.PubMedCrossRef Tuttolomondo A, Di Raimondo D, di Sciacca R, Pinto A, Licata G. Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des. 2008;14:3574–89.PubMedCrossRef
34.
go back to reference Silverstein FS, Barks JD, Hagan P, Liu XH, Ivacko J, Szaflarski J. Cytokines and perinatal brain injury. Neurochem Int. 1997;30:375–83.PubMedCrossRef Silverstein FS, Barks JD, Hagan P, Liu XH, Ivacko J, Szaflarski J. Cytokines and perinatal brain injury. Neurochem Int. 1997;30:375–83.PubMedCrossRef
35.
go back to reference Martin RL, Lloyd HGE, Cowan AI. The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends Neurosci. 1994;17:251–7.PubMedCrossRef Martin RL, Lloyd HGE, Cowan AI. The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends Neurosci. 1994;17:251–7.PubMedCrossRef
37.
go back to reference Ellis A, Bennett DL. Neuroinflammation and the generation of neuropathic pain. Br J Anaesth. 2013;111:26–37.PubMedCrossRef Ellis A, Bennett DL. Neuroinflammation and the generation of neuropathic pain. Br J Anaesth. 2013;111:26–37.PubMedCrossRef
39.
go back to reference O’Connor JJ. Targeting tumour necrosis factor-α in hypoxia and synaptic signalling. Ir J Med Sci. 2013;182:157–62.PubMedCrossRef O’Connor JJ. Targeting tumour necrosis factor-α in hypoxia and synaptic signalling. Ir J Med Sci. 2013;182:157–62.PubMedCrossRef
Metadata
Title
δ-Opioid Receptors and Inflammatory Cytokines in Hypoxia: Differential Regulation Between Glial and Neuron-Like Cells
Authors
Qinyu Wang
Dongman Chao
Tao Chen
Harleen Sandhu
Ying Xia
Publication date
01-08-2014
Publisher
Springer US
Published in
Translational Stroke Research / Issue 4/2014
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-014-0342-1

Other articles of this Issue 4/2014

Translational Stroke Research 4/2014 Go to the issue